The Chemours Company CC R2K
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -5.3% CAGR over 5 years.
- Earnings shrank at -55.6% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CC The Chemours Company R2K | 22.16 | - | $3.33B | 1.58% | -0.14% | -103.01% | -5.26% | -55.59% |
| 2 | LIN Linde plc NDXSPX | 497.69 | 33.00 | $230.11B | 1.29% | 13.07% | 18.23% | 0.62% | 18.48% |
| 3 | NEM Newmont Corporation SPX | 109.81 | 14.24 | $117.23B | 0.95% | 22.51% | 25.83% | 23.91% | 583.84% |
| 4 | FCX Freeport-McMoRan Inc. SPX | 65.71 | 34.77 | $94.46B | 0.91% | 12.93% | 15.63% | 4.39% | -14.02% |
| 5 | SHW The Sherwin-Williams Company SPX | 303.84 | 29.16 | $74.94B | 1.05% | 20.04% | 60.72% | 2.10% | 8.34% |
| 6 | CRH CRH plc SPX | 108.79 | 20.18 | $72.69B | 1.43% | 11.33% | 15.81% | 4.60% | -1.15% |
| 7 | ECL Ecolab Inc. SPX | 256.00 | 34.59 | $72.05B | 1.14% | 14.89% | 22.43% | 4.26% | 23.88% |
| 8 | APD Air Products and Chemicals, Inc. SPX | 278.62 | 29.33 | $62.04B | 2.60% | -0.62% | 12.35% | -1.77% | -39.16% |
| 9 | NUE Nucor Corporation SPX | 250.00 | 24.80 | $56.94B | 0.90% | 8.80% | 12.29% | -7.84% | -38.80% |
Quarterly Results
Figures in USD.
| Metric | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 1.44B | 1.59B | 1.58B | 1.57B | 1.73B | 1.82B | 1.63B | 1.46B | 1.38B | 1.41B | 1.39B | 1.35B | 1.30B | 1.09B | 1.23B | 1.44B | 1.66B | 1.68B | 1.76B | 1.92B | 1.78B | 1.34B | 1.55B | 1.66B | 1.50B | 1.37B | 1.36B | 1.55B | - | - | 1.37B | 1.61B | 1.50B | 1.33B | 1.38B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.13B | 1.34B | 1.26B | 1.17B | 1.17B |
| Gross Profit | - | 202.00M | 267.00M | 342.00M | - | 356.00M | 438.00M | 465.00M | - | 537.00M | 557.00M | 477.00M | - | 296.00M | 323.00M | 294.00M | - | 298.00M | 199.00M | 257.00M | 297.00M | 264.00M | 427.00M | 486.00M | 497.00M | 432.00M | - | 368.00M | 410.00M | 273.00M | - | 284.00M | 308.00M | - | - | 236.00M | 278.00M | 233.00M | 156.00M | 212.00M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 158.00M | 465.00M | 140.00M | 161.00M | 173.00M |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 78.00M | -187.00M | 93.00M | -5.00M | 39.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 154.00M | -102.00M | 198.00M | 82.00M | 126.00M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 66.00M | 67.00M | 68.00M | 68.00M | 69.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | -261.00M | 51.00M | -67.00M | -22.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.00M | 119.00M | -9.00M | -5.00M | 7.00M |
| Net Income | -86.00M | 51.00M | -18.00M | 204.00M | -230.00M | 150.00M | 161.00M | 207.00M | 228.00M | 297.00M | 281.00M | 275.00M | 142.00M | 94.00M | 96.00M | 76.00M | -317.00M | 100.00M | 24.00M | 76.00M | 96.00M | 66.00M | 214.00M | 234.00M | 201.00M | 240.00M | -97.00M | 145.00M | -376.00M | 12.00M | -18.00M | 54.00M | 60.00M | - | - | -5.00M | -381.00M | 60.00M | -61.00M | -29.00M |
| Diluted EPS | -0.48 | 0.28 | -0.10 | 1.11 | -1.26 | 0.79 | 0.84 | 1.08 | 1.19 | 1.58 | 1.53 | 1.51 | 0.81 | 0.55 | 0.57 | 0.46 | -1.94 | 0.61 | 0.15 | 0.46 | 0.57 | 0.39 | 1.27 | 1.43 | 1.26 | 1.52 | -0.65 | 0.96 | -2.52 | 0.08 | -0.12 | 0.36 | 0.39 | -0.18 | - | -0.03 | -2.54 | 0.40 | - | -0.19 |
| R&D Expense | - | 23.00M | 17.00M | 19.00M | - | 19.00M | 21.00M | 20.00M | - | 20.00M | 20.00M | 20.00M | - | 22.00M | 19.00M | 20.00M | - | 24.00M | 20.00M | 22.00M | 24.00M | 27.00M | 27.00M | 30.00M | 25.00M | 32.00M | - | 26.00M | 28.00M | 28.00M | - | 28.00M | 26.00M | 29.00M | - | 27.00M | 28.00M | 26.00M | - | 26.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 5.40B | 6.18B | 6.64B | 5.53B | 4.97B | 6.34B | 6.83B | 6.08B | 5.78B | 5.81B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | 5.21B | 4.78B | 4.64B | 4.91B |
| Gross Profit | 1.46B | 1.36B | 955.00M | 1.10B | 1.75B | 1.97B | 1.06B | 1.07B | 1.38B | 1.62B | 1.30B | 1.14B | 902.00M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | 830.00M | 1.43B | 721.00M | 930.00M |
| Operating Income | - | - | - | - | - | - | - | - | - | 786.00M | -123.00M | 421.00M | -28.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | 1.20B | 199.00M | 661.00M | 332.00M |
| Interest Expense | - | - | - | - | - | - | - | - | - | 163.00M | 208.00M | 263.00M | 269.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | 741.00M | -318.00M | 106.00M | -277.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - | 163.00M | -66.00M | 37.00M | 109.00M |
| Net Income | 423.00M | 400.00M | -90.00M | 7.00M | 746.00M | 995.00M | -52.00M | 219.00M | 608.00M | 578.00M | -253.00M | 69.00M | -386.00M |
| Diluted EPS | 2.34 | 2.21 | -0.50 | 0.04 | 3.91 | 5.45 | -0.32 | 1.32 | 3.60 | 3.65 | -1.70 | 0.57 | -2.57 |
| R&D Expense | 164.00M | 143.00M | 97.00M | 81.00M | 81.00M | 82.00M | 80.00M | 93.00M | 107.00M | 118.00M | 108.00M | 109.00M | 108.00M |
Compounded Sales Growth
| 5 Years: | -5.26% |
| 1 Year: | 1.00% |
Compounded Profit Growth
| 5 Years: | -55.59% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +123.55% |
| 6 Months: | +81.43% |
| 3 Months: | +21.92% |
| 1 Month: | -15.57% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 5.96B | 6.30B | 6.06B | 7.29B | 7.36B | 7.26B | 7.08B | - | 7.64B | - | - | - | 8.25B | 7.51B | 7.38B | 7.46B | 7.55B | 7.38B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | 3.21B | - | - | - | 3.83B | 3.02B | - | - | - | 3.00B |
| Cash & Equivalents | - | 0 | 0 | 366.00M | 902.00M | 1.56B | 1.20B | 943.00M | 1.10B | - | 1.10B | - | - | - | 1.20B | 713.00M | - | - | - | 670.00M |
| Inventory | - | - | - | - | - | - | - | - | - | - | 1.40B | - | - | - | 1.35B | 1.46B | - | - | - | 1.57B |
| Receivables | - | - | - | - | - | - | - | - | - | - | 509.00M | - | - | - | 509.00M | 619.00M | - | - | - | 562.00M |
| Total Liabilities | - | - | 2.29B | 6.17B | 5.96B | 6.43B | 6.34B | 6.56B | 6.27B | - | 6.53B | - | - | 7.20B | 7.51B | 6.94B | 6.81B | 7.23B | - | 7.13B |
| Current Liabilities | - | - | 1.40B | 1.47B | 1.77B | 1.65B | 1.71B | 1.54B | 1.44B | - | 1.89B | 1.75B | 2.19B | 2.92B | 2.49B | 1.82B | 1.67B | 1.83B | 1.87B | 1.69B |
| Long Term Debt | - | - | 0 | 3.92B | 3.53B | 4.10B | 3.96B | 4.03B | 4.00B | - | 3.59B | - | - | - | 3.99B | 4.06B | 4.07B | 4.11B | 4.10B | 4.10B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | 3.88B | - | - | - | 4.30B | 4.37B | - | - | - | 4.39B |
| Total Equity | 3.17B | - | 3.67B | 126.00M | 100.00M | 860.00M | 1.01B | 689.00M | 813.00M | - | 1.11B | - | - | - | 737.00M | 571.00M | 566.00M | 228.00M | 274.00M | 250.00M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 195.38M | - | - | - | 197.52M | 198.30M | - | - | - | 198.72M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 798.00M | 505.00M | 182.00M | 594.00M | 640.00M | 1.14B | 650.00M | 807.00M | - | 755.00M | 556.00M | -633.00M | 264.00M |
| Investing Cash Flow | -424.00M | -560.00M | -497.00M | 357.00M | -370.00M | -487.00M | -483.00M | -234.00M | - | -284.00M | -229.00M | -353.00M | -206.00M |
| Financing Cash Flow | -374.00M | 55.00M | 687.00M | -396.00M | 352.00M | -993.00M | -419.00M | -449.00M | - | -686.00M | 172.00M | -36.00M | -126.00M |
| Capital Expenditure | -438.00M | -604.00M | -519.00M | -338.00M | -411.00M | -498.00M | -481.00M | -267.00M | - | -307.00M | -370.00M | -360.00M | -213.00M |
| Free Cash Flow | 360.00M | -99.00M | -337.00M | 256.00M | 229.00M | 642.00M | 169.00M | 540.00M | - | 448.00M | 186.00M | -993.00M | 51.00M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | -215.00M | 499.00M | -1.02B | -68.00M |
| Share Buybacks | - | - | - | 0 | 106.00M | 644.00M | 322.00M | 0 | 173.00M | 495.00M | 69.00M | - | - |
| Dividends Paid | 0 | 0 | 105.00M | 22.00M | 22.00M | 148.00M | 164.00M | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | 20.4% | 28.2% | 29.7% | 19.2% | 21.5% | 21.8% | 23.7% | 21.4% | 19.8% | 15.5% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | 11.5% | -2.0% | 7.3% | -0.5% |
| Net Margin % | - | - | - | 0.1% | 12.1% | 15.0% | -0.9% | 4.4% | 9.6% | 8.5% | -4.2% | 1.2% | -6.6% |
| ROE % | - | 10.9% | -71.4% | 7.0% | 86.7% | 98.1% | -7.5% | 26.9% | - | 52.2% | -34.3% | 12.1% | -154.4% |
| ROCE % | - | - | - | - | - | - | - | - | - | 13.7% | -2.1% | 7.4% | -0.5% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 14.89% | 22.39M | $496.07M |
| 2 | Vanguard Portfolio Management LLC | 6.87% | 10.33M | $228.81M |
| 3 | Vanguard Capital Management LLC | 4.50% | 6.77M | $150.11M |
| 4 | State Street Corporation | 4.07% | 6.12M | $135.69M |
| 5 | Ameriprise Financial, Inc. | 3.22% | 4.84M | $107.21M |
| 6 | American Century Companies Inc | 2.94% | 4.42M | $97.86M |
| 7 | JPMORGAN CHASE & CO | 2.53% | 3.80M | $84.23M |
| 8 | Wolf Hill Capital Management, LP | 2.45% | 3.69M | $81.77M |
| 9 | Geode Capital Management, LLC | 2.40% | 3.60M | $79.86M |
| 10 | Goldman Sachs Group Inc | 2.00% | 3.01M | $66.79M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CC